Prospective Study
Copyright ©The Author(s) 2024.
World J Hepatol. May 27, 2024; 16(5): 822-831
Published online May 27, 2024. doi: 10.4254/wjh.v16.i5.822
Table 1 Main characteristics of cirrhosis patients with increased and normal presepsin levels, n (%)

Patients with increased presepsin level
Patients with normal presepsin level
P value
Age, yr49 (43-59)52 (42-56)0.868
Body mass index, kg/m225.9 (24.7-30.1)25.3 (21.6-28.4)0.275
Male/female12/157/140.316
Etiology of cirrhosis: Alcohol13 (48.1)10 (47.6)> 0.050
HBV3 (11.1)-
HCV3 (11.1)3 (14.3)
Metabolic dysfunction-associated steatotic liver disease2 (7.4)1 (4.8)
Mixed4 (14.8)3 (14.3)
Cryptogenic2 (7.4)4 (18.0)
Child–Pugh score9 (8-10)8 (7-9)0.009
Esophageal varices (Grade 1)9 (33.3)9 (42.9)0.353
Esophageal varices (Grade 2-3)15 (55.5)10 (47.6)0.399
Minimal hepatic encephalopathy19 (70.4)14 (66.7)0.588
Overt hepatic encephalopathy1 (3.7)3 (14.3)0.215
Ascites21 (77.7)16 (76.2)0.582
Ascites (Grade 1)11 (40.7)12 (57.1)0.201
Ascites (Grade 2-3)10 (37.0)4 (19.0)0.149
Serum total protein, g/L73 (65-76)70 (61-74)0.344
Serum albumin, g/L32 (30-34)35 (33-37)0.049
Serum total bilirubin, μmol/L60 (36-78)37 (26-57)0.022
International normalized ratio1.63 (1.39-1.75)1.48 (1.36-1.61)0.151
Red blood cells, 1012 cell/L3.6 (3.1-4.2)3.6 (3.3-4.2)0.934
White blood cells, 109 cell/L3.7 (2.6-5.2)3.3 (2.6-5.9)0.942
Platelets, 109 cell/L94 (52-104)94 (66-105)0.64
Serum creatinine, μmol/L77 (67-91)76 (66-107)0.625
Serum sodium, mmol/L141 (139-142)141 (140-142)0.983
Alanine aminotransferase, U/L26 (18-50)28 (20-45)0.723
Aspartate aminotransferase, U/L52 (41-77)48 (28-51)0.151
Gamma glutamyl transferase, U/L72 (44-114)68 (37-269)0.575
Alkaline phosphatase, U/L261 (194-330)242 (215-388)0.506
C-reactive protein, mg/L9 (5-15)7 (3-12)0.399
Splenic length, cm15.0 (13.0-17.0)15.0 (13.2-18.4)0.708
Table 2 Significant correlations between blood presepsin levels and gut microbiota taxa
Direct correlations
Inverse correlations
Taxon rank
Taxon
R, P value
Taxon rank
Taxon
R, P value
PhylumProteobacteria0.316, 0.029FamilyLachnospiraceae0.447, 0.0421
ClassBacilli0.470, 0.0321Propionibacteriaceae-0.302, 0.038
Gammaproteobacteria0.351, 0.014GenusFusicatenibacter-0.297, 0.040
FamilyErysipelatoclostridiaceae0.384, 0.007Holdemanella-0.315, 0.029
Eubacteriaceae0.340, 0.018
Vibrionaceae0.366, 0.010
Xanthobacteraceae0.363, 0.011
GenusEscherichia-Shigella0.338, 0.019
Stenotrophomonas0.365, 0.011
Vibrio0.346, 0.016
Table 3 Change in the values of the main cirrhosis indicators as a result of the probiotic (Saccharomyces boulardii) taking, depending on the baseline presepsin level, n (%)

Elevated baseline presensin level (n = 13)
Normal baseline presensin level (n = 9)

At the beginning of the study
After the probiotic course
P value
At the beginning of the study
After the probiotic course
P value
Child–Pugh score9 (8-11)7 (6-9)0.0048 (7-8)7 (6-8)0.124
Child–Pugh class, A/B+C0/135/80.0200/92/70.235
No hepatic encephalopathy 2 (15.4)8 (61.5)0.0212 (22.2)3 (33.3)0.500
Ascites12 (92.3)5 (38.4)0.0068 (88.9)5 (55.5)0.147
Serum albumin, g/L32 (30-34)33 (32-39)0.03335 (33-36)38 (37-39)0.008
Serum total bilirubin, μmol/L52 (36-120)29 (26-40)0.01634 (26-44)25 (22-35)0.066
Alanine aminotransferase, U/L26 (18-47)26 (18-40)0.27230 (21-41)33 (25-39)0.813
Aspartate aminotransferase, U/L60 (37-75)39 (27-51)0.01245 (28-51)36 (36-42)0.314
Gamma glutamyl transferase, U/L92 (44-207)56 (40-89)0.19637 (31-317)62 (30-115)0.193
Alkaline phosphatase, U/L268 (245-355)210 (187-245)0.013261 (227-446)215 (188-275)0.110